Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: Population based study of coronary heart disease

Heart

Volumn 81, Issue 3, 1999, Pages 245-247

  Danesh, J ^a   Wong, Y ^b   Ward, M ^b   Muir, J ^c  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Chlamydia pneumoniae; Cytomegalovirus; Helicobacter pylori; Ischaemic heart disease

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; FEMALE; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; VIRUS INFECTION;

EID: 0032971457     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.81.3.245     Document Type: Article

References (19)

1. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96:4095-103.
2. Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
3. Gurfinkel E, Bozovich G, Daroca A, et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997;350:404-7.
4. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-14.
5. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
6. Danesh J, Appleby P. Persistent infection and vascular disease: a systematic review. Expert Opin Invest Drugs 1998; 7:691-713.
7. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implication for screening in primary care. BMJ 1991; 302:1057-60.
8. Wong YK, Ward M. The species specificity of the microimmunofluorescence antibody test and comparisons with time resolved fluoroscopic immunoassay. J Clin Pathol. [In press].
9. Easterbrook P, Berlin J, Gopalan R, et al. Publication bias in clinical research. Lancet 1991;337:867-72.
10. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998;316:1130-2.
11. Wald NJ, Law MR, Morris JK, et al. Helicobacter pylori infection and mortality from ischaemic heart disease: negative results from a large, prospective study. BMJ 1997;315: 1199-201.
12. Aromaa A, Knekt P, Reunanen A, et al. Helicobacter pylori and the risk of myocardial infarction [abstract]. Gut 1996; 39(suppl 2):A91.
13. Whincup PH, Mendall MA, Perry IJ, et al. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle-aged men. Heart 1996;75: 568-72.
14. Folsom AR, Nieto FJ, Sorlie P, et al. No association of Helicobacter pylori seropositivity with coronary heart disease in a prospective study [abstract]. Circulation 1997;96(suppl I):I-100.
15. Miettinen H, Lehto S, Saikku P, et al. Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Ear Heart J 1996;17:682-8.
16. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992;116:273-8.
17. Ossewarde JM, Vallinga C, Feskens EJM, et al. Infection with Chlamydia pneumoniac as a risk factor for coronary heart disease (the Zutphen elderly study) [abstract]. Atherosclerosis 1995;115(suppl):S13.
18. Kark JD, Leionen M, Paltiel O. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. Int J Epidemiol 1997;4:730-8.
19. Viik-Kajander M, Roivainen M, Manninen V, et al. Herpes virus infections and the risk of myocardial infarction and coronary death [abstract]. Circulation 1997;96(suppl I):I-374.